Titre : Phénylurées

Phénylurées : Questions médicales fréquentes

Termes MeSH sélectionnés :

Quantitative Structure-Activity Relationship
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Phénylurées : Questions médicales les plus fréquentes", "headline": "Phénylurées : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Phénylurées : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-03-12", "dateModified": "2025-03-07", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Phénylurées" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Dérivés du benzène", "url": "https://questionsmedicales.fr/mesh/D001555", "about": { "@type": "MedicalCondition", "name": "Dérivés du benzène", "code": { "@type": "MedicalCode", "code": "D001555", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Dérivés de la diphényl-urée", "alternateName": "Carbanilides", "url": "https://questionsmedicales.fr/mesh/D002224", "about": { "@type": "MedicalCondition", "name": "Dérivés de la diphényl-urée", "code": { "@type": "MedicalCode", "code": "D002224", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Imidocarbe", "alternateName": "Imidocarb", "url": "https://questionsmedicales.fr/mesh/D007095", "about": { "@type": "MedicalCondition", "name": "Imidocarbe", "code": { "@type": "MedicalCode", "code": "D007095", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.202.400" } } } ] }, { "@type": "MedicalWebPage", "name": "Céliprolol", "alternateName": "Celiprolol", "url": "https://questionsmedicales.fr/mesh/D017272", "about": { "@type": "MedicalCondition", "name": "Céliprolol", "code": { "@type": "MedicalCode", "code": "D017272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.241" } } }, { "@type": "MedicalWebPage", "name": "Diuron", "alternateName": "Diuron", "url": "https://questionsmedicales.fr/mesh/D004237", "about": { "@type": "MedicalCondition", "name": "Diuron", "code": { "@type": "MedicalCode", "code": "D004237", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.397" } } }, { "@type": "MedicalWebPage", "name": "Linuron", "alternateName": "Linuron", "url": "https://questionsmedicales.fr/mesh/D008044", "about": { "@type": "MedicalCondition", "name": "Linuron", "code": { "@type": "MedicalCode", "code": "D008044", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D02.455.426.559.389.703.515" } } } ], "about": { "@type": "MedicalCondition", "name": "Phénylurées", "alternateName": "Phenylurea Compounds", "code": { "@type": "MedicalCode", "code": "D010671", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Lin Hao", "url": "https://questionsmedicales.fr/author/Lin%20Hao", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Chun Wang", "url": "https://questionsmedicales.fr/author/Chun%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. chunwang69@126.com." } }, { "@type": "Person", "name": "Qiuhua Wu", "url": "https://questionsmedicales.fr/author/Qiuhua%20Wu", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China. qiuhuawu@126.com." } }, { "@type": "Person", "name": "Zhi Wang", "url": "https://questionsmedicales.fr/author/Zhi%20Wang", "affiliation": { "@type": "Organization", "name": "Department of Chemistry, College of Science, Hebei Agricultural University, Baoding, 071001, China." } }, { "@type": "Person", "name": "Weihua Liu", "url": "https://questionsmedicales.fr/author/Weihua%20Liu", "affiliation": { "@type": "Organization", "name": "College of Science, Hebei Agricultural University, Baoding 071001, Hebei, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Systematic computational toxicity analysis of the ozonolytic degraded compounds of azo dyes: Quantitative structure-activity relationship (QSAR) and adverse outcome pathway (AOP) based approach.", "datePublished": "2023-05-20", "url": "https://questionsmedicales.fr/article/37217122", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.envres.2023.116142" } }, { "@type": "ScholarlyArticle", "name": "Virtual screening, identification, and potential antioxidant mechanism of novel bioactive peptides during aging by a short-chain peptidomics, quantitative structure-activity relationship analysis, and molecular docking.", "datePublished": "2023-06-11", "url": "https://questionsmedicales.fr/article/37689894", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.foodres.2023.113129" } }, { "@type": "ScholarlyArticle", "name": "Development of reliable quantitative structure-toxicity relationship models for toxicity prediction of benzene derivatives using semiempirical descriptors.", "datePublished": "2022-09-07", "url": "https://questionsmedicales.fr/article/36042574", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/15376516.2022.2118092" } }, { "@type": "ScholarlyArticle", "name": "Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain.", "datePublished": "2023-04-05", "url": "https://questionsmedicales.fr/article/37028177", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiolchem.2023.107864" } }, { "@type": "ScholarlyArticle", "name": "Prediction of antioxidant peptides using a quantitative structure-activity relationship predictor (AnOxPP) based on bidirectional long short-term memory neural network and interpretable amino acid descriptors.", "datePublished": "2023-01-24", "url": "https://questionsmedicales.fr/article/36701965", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.compbiomed.2023.106591" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Composés chimiques organiques", "item": "https://questionsmedicales.fr/mesh/D009930" }, { "@type": "ListItem", "position": 3, "name": "Hydrocarbures", "item": "https://questionsmedicales.fr/mesh/D006838" }, { "@type": "ListItem", "position": 4, "name": "Hydrocarbures cycliques", "item": "https://questionsmedicales.fr/mesh/D006844" }, { "@type": "ListItem", "position": 5, "name": "Hydrocarbures aromatiques", "item": "https://questionsmedicales.fr/mesh/D006841" }, { "@type": "ListItem", "position": 6, "name": "Dérivés du benzène", "item": "https://questionsmedicales.fr/mesh/D001555" }, { "@type": "ListItem", "position": 7, "name": "Phénylurées", "item": "https://questionsmedicales.fr/mesh/D010671" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Phénylurées - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Phénylurées", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-05", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Phénylurées", "description": "Comment diagnostiquer une intoxication aux phénylurées ?\nQuels tests sont utilisés pour détecter les phénylurées ?\nQuels symptômes indiquent une exposition aux phénylurées ?\nLes phénylurées sont-elles détectables par imagerie ?\nQuel rôle joue l'historique médical dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Phénylurées", "description": "Quels sont les symptômes courants des phénylurées ?\nLes phénylurées provoquent-elles des réactions allergiques ?\nPeut-on avoir des symptômes neurologiques ?\nLes symptômes varient-ils selon la dose ?\nY a-t-il des symptômes à long terme ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Phénylurées", "description": "Comment prévenir l'exposition aux phénylurées ?\nLes travailleurs doivent-ils être formés ?\nDes contrôles réguliers sont-ils nécessaires ?\nLes enfants sont-ils plus à risque ?\nQuelles mesures de sécurité doivent être appliquées ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Phénylurées", "description": "Quel est le traitement principal pour l'intoxication ?\nDes antidotes existent-ils pour les phénylurées ?\nComment gérer les symptômes neurologiques ?\nLe traitement nécessite-t-il une hospitalisation ?\nY a-t-il des traitements préventifs ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Phénylurées", "description": "Quelles complications peuvent survenir ?\nLes phénylurées peuvent-elles causer des cancers ?\nY a-t-il des effets sur la reproduction ?\nLes complications sont-elles réversibles ?\nComment surveiller les complications ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Phénylurées", "description": "Quels sont les principaux facteurs de risque ?\nLes antécédents familiaux jouent-ils un rôle ?\nLes personnes âgées sont-elles plus à risque ?\nLes femmes enceintes doivent-elles être prudentes ?\nLes habitudes de vie influencent-elles le risque ?", "url": "https://questionsmedicales.fr/mesh/D010671?mesh_terms=Quantitative+Structure-Activity+Relationship&page=5#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une intoxication aux phénylurées ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic se fait par des tests sanguins et l'évaluation des symptômes cliniques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour détecter les phénylurées ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des analyses de sang et d'urine peuvent être effectuées pour détecter ces composés." } }, { "@type": "Question", "name": "Quels symptômes indiquent une exposition aux phénylurées ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des troubles neurologiques, des éruptions cutanées et des nausées." } }, { "@type": "Question", "name": "Les phénylurées sont-elles détectables par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Non, l'imagerie ne détecte pas les phénylurées, des tests biochimiques sont nécessaires." } }, { "@type": "Question", "name": "Quel rôle joue l'historique médical dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "L'historique médical aide à identifier les expositions potentielles aux phénylurées." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des phénylurées ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent des maux de tête, des vertiges et des troubles digestifs." } }, { "@type": "Question", "name": "Les phénylurées provoquent-elles des réactions allergiques ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent provoquer des éruptions cutanées et des démangeaisons chez certains individus." } }, { "@type": "Question", "name": "Peut-on avoir des symptômes neurologiques ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des symptômes comme des convulsions ou des troubles de la coordination peuvent survenir." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon la dose ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la gravité des symptômes dépend de la dose et de la durée d'exposition." } }, { "@type": "Question", "name": "Y a-t-il des symptômes à long terme ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Des effets neurologiques ou rénaux peuvent persister après une exposition prolongée." } }, { "@type": "Question", "name": "Comment prévenir l'exposition aux phénylurées ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez les produits chimiques contenant des phénylurées et portez des équipements de protection." } }, { "@type": "Question", "name": "Les travailleurs doivent-ils être formés ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une formation sur les risques et les mesures de sécurité est essentielle." } }, { "@type": "Question", "name": "Des contrôles réguliers sont-ils nécessaires ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des contrôles réguliers de l'environnement de travail peuvent réduire les risques." } }, { "@type": "Question", "name": "Les enfants sont-ils plus à risque ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants peuvent être plus sensibles aux effets des phénylurées." } }, { "@type": "Question", "name": "Quelles mesures de sécurité doivent être appliquées ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Utilisez des gants, des masques et des lunettes de protection lors de la manipulation." } }, { "@type": "Question", "name": "Quel est le traitement principal pour l'intoxication ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement consiste en l'élimination de l'exposition et le soutien symptomatique." } }, { "@type": "Question", "name": "Des antidotes existent-ils pour les phénylurées ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas d'antidote spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Comment gérer les symptômes neurologiques ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des médicaments anticonvulsivants peuvent être prescrits pour contrôler les convulsions." } }, { "@type": "Question", "name": "Le traitement nécessite-t-il une hospitalisation ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Une hospitalisation peut être nécessaire en cas de symptômes graves ou persistants." } }, { "@type": "Question", "name": "Y a-t-il des traitements préventifs ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Éviter l'exposition aux phénylurées est la meilleure prévention contre l'intoxication." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des complications neurologiques, rénales ou hépatiques peuvent se développer après exposition." } }, { "@type": "Question", "name": "Les phénylurées peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines études suggèrent un lien potentiel avec des cancers, mais des recherches sont nécessaires." } }, { "@type": "Question", "name": "Y a-t-il des effets sur la reproduction ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des effets néfastes sur la reproduction ont été observés dans certains modèles animaux." } }, { "@type": "Question", "name": "Les complications sont-elles réversibles ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Certaines complications peuvent être réversibles, mais d'autres peuvent être permanentes." } }, { "@type": "Question", "name": "Comment surveiller les complications ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Des examens médicaux réguliers et des tests de fonction organique sont recommandés." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'exposition professionnelle, l'utilisation de produits chimiques et la génétique sont des facteurs clés." } }, { "@type": "Question", "name": "Les antécédents familiaux jouent-ils un rôle ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'effets néfastes." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent être plus vulnérables aux effets des phénylurées." } }, { "@type": "Question", "name": "Les femmes enceintes doivent-elles être prudentes ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les femmes enceintes doivent éviter l'exposition en raison des risques pour le fœtus." } }, { "@type": "Question", "name": "Les habitudes de vie influencent-elles le risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des habitudes de vie saines peuvent réduire le risque d'effets néfastes." } } ] } ] }

Sources (10000 au total)

Systematic computational toxicity analysis of the ozonolytic degraded compounds of azo dyes: Quantitative structure-activity relationship (QSAR) and adverse outcome pathway (AOP) based approach.

The present study identifies and analyses the degraded products of three azo dyes (Reactive Orange 16, Reactive Red 120, and Direct Red 80) and proffers their in silico toxicity predictions. In our pr...

Virtual screening, identification, and potential antioxidant mechanism of novel bioactive peptides during aging by a short-chain peptidomics, quantitative structure-activity relationship analysis, and molecular docking.

Antioxidant peptides have received a great deal of attention. However, only a few studies have been conducted on the antioxidant peptides originating from Baijiu. A total of 1490 features deemed poten...

Computational characteristics of the structure-activity relationship of inhibitors targeting Pks13-TE domain.

Multiple studies have established the Pks13-TE domain as a promising target for anti-tuberculosis drug development. However, recent findings have revealed that the lead compound currently in the pipel...

Prediction of antioxidant peptides using a quantitative structure-activity relationship predictor (AnOxPP) based on bidirectional long short-term memory neural network and interpretable amino acid descriptors.

Antioxidant peptides can protect against free radical-mediated diseases, especially food-derived antioxidant peptides are considered as potential competitors among synthetic antioxidants due to their ...

Amorphous zirconium oxide activates peroxymonosulfate for selective degradation of organic compounds: Performance, mechanisms and structure-activity relationship.

Application of heterogeneous advanced oxidation processes (AOPs) for wastewater treatment suffers from the low oxidant utilization efficiency, slow catalytic cycling and severe matrix interference. He...

Risk assessment of the asthma-induction potential of substances in spray products for car cabin detailing - based on EU's Chemical Agents Directive, using harmonised classifications and quantitative structure-activity relationship (QSAR).

Exposure to spray-formulated products for car cabin detailing is a potential risk for asthma induction. With a focus on the asthma-related endpoints sensitisation and irritation of the lungs, we perfo...

Structure-activity relationships of dihydropyrimidone inhibitors against native and auto-processed human neutrophil elastase.

Human neutrophil elastase (HNE) is a key driver of systemic and cardiopulmonary inflammation. Recent studies have established the existence of a pathologically active auto-processed form of HNE with r... AutoDock Vina v1.2.0 and Cresset Forge v10 software were used to develop a 3D-QSAR model for a series of 47 DHPI inhibitors. Molecular Dynamics (MD) simulations were carried out using AMBER v18 to stu... The DHPI inhibitors occupy the S1 and S2 subsites of scHNE. The robust 3D-QSAR model showed acceptable predictive and descriptive capability with regression coefficient of r... SAR insights gained from this study will aid the future development of inhibitors active against both forms of HNE....